Fabry Aim Children Early (ACE) Project

NCT04965467 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-09-30

No results posted yet for this study

Summary

The purpose of this study is to assess the frequency of Fabry disease in children with early symptoms.

Conditions

Interventions

DIAGNOSTIC_TEST

Screening for Fabry disease

A questionnaire specifically designed to assess Fabry disease-associated phenotypes in infancy, childhood and adolescence: pain in the hands and feet, angiokeratomas, hypohidrosis, corneal whorls, unexplained renal failure, unexplained hypertrophic myocardiopathy and unexplained early onset stroke. The questionnaire consisted mainly of quantitative, closed questions with pre- defined response options.The diagnosis of FD will be performed by standard procedures following international recommendations. These require the search for a deficiency of alphagalactosidase A activity on leucocytes in males and genetic analysis of the GLA gene in females (Germain et al. 2010). In females plasma Gb3, globotriaosyl- sphingosine (lyso-Gb3) will be measured for screening.

Sponsors & Collaborators

  • Children's Hospital of Nanjing Medical University

    collaborator OTHER
  • The Children's Hospital of Zhejiang University School of Medicine

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Children's Hospital Affiliated to Zhengzhou University/Henan Children's Hospital

    collaborator UNKNOWN
  • Anhui Provincial Children's Hospital

    collaborator OTHER
  • Beijing Children's Hospital

    collaborator OTHER
  • Tianjin Children's Hospital

    collaborator OTHER
  • Children's Hospital of Hebei Province

    collaborator OTHER
  • Shanxi Provincial Maternity and Children's Hospital

    collaborator OTHER
  • Xiamen Maternal and Child Care Hospital

    collaborator UNKNOWN
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • Children's Hospital of Chongqing Medical University

    collaborator OTHER
  • West China Second University Hospital

    collaborator OTHER
  • Kunming Children's Hospital

    collaborator OTHER
  • Xian Children's Hospital

    collaborator OTHER_GOV
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • Xinjiang Urumqi Children's Hospital.

    collaborator UNKNOWN
  • Hunan Children's Hospital

    collaborator OTHER_GOV
  • Inner Mongolia Maternal and Child Healthcare Hospital

    collaborator UNKNOWN
  • Sichuan provincial maternity and child health care hospital

    collaborator UNKNOWN
  • Children's Hospital of Fudan University

    lead OTHER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-27
Primary Completion
2022-02-20
Completion
2022-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04965467 on ClinicalTrials.gov